Cognizant (CTSH) Up 6.7% Since Last Earnings Report: Can It Continue?

Cognizant reported better-than-expected Q3 2025 results with non-GAAP EPS of $1.39 (+11.2% y/y; +7.75% vs. Zacks est.) and revenues of $5.42 billion (+7.4% y/y; +1.63% vs. consensus), driven by North America, organic growth and acquisitions (≈250 bps contribution). Bookings on a trailing-12-month basis rose 5% to $27.5 billion (book-to-bill ~1.3x), GAAP and adjusted operating margins expanded to 16%, cash/short-term investments rose to $2.35 billion while total debt fell to $584 million, and cash from operations/free cash flow surged to $1.227 billion and $1.16 billion respectively. Management guided Q4 revenue to $5.27–$5.33 billion and full-year 2025 revenue to $21.05–$21.10 billion with adjusted EPS of $5.22–$5.26 and a ~15.7% adjusted margin; analysts have trended estimates upward and the stock carries a Zacks Rank #2 (Buy).

Analysis

Market structure: Cognizant (CTSH) is the clear near-term beneficiary of enterprise cloud/data modernization and early generative-AI spending — evidenced by 3,500+ AI engagements (40% QoQ) and a TTM bookings of $27.5B (book-to-bill ~1.3). Large hyperscalers and GPU vendors (NVDA, MSFT, AMZN) also gain from higher services demand; lower-cost pure-play offshore vendors (e.g., INFY) face relative margin pressure as clients pay premiums for AI/cloud systems integrators. Strong free cash flow ($1.16B Q3) and modest net debt ($~0.6B) tighten credit spreads and reduce CTSH bond risk in fixed income markets.

Risk assessment: Tail risks include a sharp corporate capex/AI pause that could flip bookings (TTM) from +5% to negative within 2–4 quarters, and data-localization/regulatory actions that increase cost of delivery in key markets. Short-term (days–weeks) risk is pre-earnings volatility and momentum F rating; medium-term (3–9 months) depends on execution of Q4 guidance ($5.27–$5.33B) and large-deal conversion; long-term (12–24 months) hinges on sustained AI spend versus rising delivery costs and M&A integration (250bps contributed this quarter).

Trade implications: Establish a 2–3% long position in CTSH (target +15–20% in 6–9 months) with a hard stop at -10% or if TTM bookings drop < $26B. Implement a relative-value pair: long CTSH / short INFY (equal notional) to capture premium re-rating and margin expansion. Use options: buy 6–9 month CTSH call spread (buy 2.5–3.0 delta, sell strike ~20–25% higher) to limit premium and ride catalysts (large-deal announcements, Jan–May 2026 earnings).

Contrarian angles: Consensus underprices FCF conversion upside — Q3 FCF jumped >3x QoQ, supporting potential buybacks/dividend or accelerated debt paydown that the market may not price. Conversely, the market could be underestimating margin risk if rapid AI rollouts force heavy reskilling/contractor spend; watch book-to-bill inflection to <1.0 as a 30–60 day sell signal. Historical parallel: 2017–19 cloud cycle shows services leaders re-rate quickly once large deals convert; failure to convert is the asymmetric downside.

Key Decisions for Investors

• Establish a 2–3% long position in CTSH (buy shares) sized to portfolio risk budget; target +15–20% upside over 6–9 months; implement stop-loss at -10% or if trailing 12-mo bookings fall below $26B.
• Initiate a relative-value pair trade: long CTSH / short INFY (equal notional) to exploit CTSH’s improving margins and INFY’s stagnant estimate revisions; rebalance after next 2 quarters or after CTSH reports two consecutive quarters of bookings growth >3% QoQ.
• Buy a 6–9 month CTSH call spread to leverage catalytic upside (example: buy 2.5–3.0 delta calls, sell strike ~20–25% higher) to limit premium outlay; increase size on confirmed large-deal announcements or Q4 guidance beat.
• Allocate +1–2% tactical exposure to NVDA and MSFT (long) as indirect beneficiaries of increased AI services demand; reduce broad offshore IT exposure by 1–2% where momentum and estimate revisions are weak.
• Monitor three triggers within 30–60 days: (1) TTM bookings change >±5%, (2) Q4 revenue versus $5.27–$5.33B guidance, and (3) announced large deals (> $100M) count; cut exposure if any two triggers are negative.